We use first and third-party cookies to offer our services and collect statistical data. If you continue browsing this website you accept their use. More information Accept
ABOUT US / LESVI
Development and manufacturing of FDFs

IS A B2B SOLUTIONS PROVIDER DEDICATED TO THE DEVELOPMENT AND MANUFACTURING OF FINISHED DOSAGE FORMS (FDFs)

across multiple technologies

LESVI

YOUR ONE-STOP-SHOP FOR ALL NEURAXPHARM's B2B ACTIVITIES

We offer the complete range of Neuraxpharm’s FDF products (quality generics, pharmaceuticals and nutraceuticals) including access to our regulatory dossiers, which can be filed with regulatory/health authorities worldwide.
  • CNS 
PHARMACEUTICALS
    CNS
    PHARMACEUTICALS
    MORE
  • CNS 
NUTRACEUTICALS
    CNS
    NUTRACEUTICALS
    MORE
  • OTHER 
PHARMACEUTICALS
    OTHER
    PHARMACEUTICALS
    MORE

EXPERTISE IN ORAL SOLID AND IN STERILE AND NON-STERILE LIQUID FORMS

Lesvi’s activity focuses on the development and manufacturing 
of oral solid and sterile and non-sterile liquid forms
MORE
We focus on the development of oral and solid sterile forms

FOCUS

Development, manufacturing and control of generic pharmaceutical specialties, both for
the Group and other laboratories, performed at Lesvi facilities in Sant Joan Despí (Barcelona), Spain

Marketing authorisations in virtually all countries worldwide and issuance of patents related to both active
substances and pharmaceutical formulations
Lesvi delivering
Headquartered in Barcelona (Spain)
LESVI
DELIVERS FDFs ALL OVER THE WORLD
Our highly flexible approach and extensive experience in the development and manufacturing
of finished dosage forms have enabled us to become reliable partners for both large national
and international third-party laboratories
Lesvi is predominantly active in the CNS area; however our portfolio also consists of antiemetic, anti-infective, cardiovascular and pain products.

Apart from dossier licensing and product supply opportunities, we also offer contract manufacturing
(CMO) services using our Blow-Fill-Seal technology to produce products in solution in preservative-free unit dose containers, mainly for ophthalmics.
Lesvi owns dossiers available for licensing

MEETING THE HIGHEST STANDARDS REQUIRED WITH EU GMP APPROVAL